Ключевые слова
Как цитировать
Аннотация
To study seroprevalence of Toxocara antibody Immunoglobulin G (IgG) and epidemiological risk factors as well as assessment the immunological pattern including cytokines, interleukin-6 (IL6) and interleukin-10 (IL-10) and immunoglobulin E (IgE) among epileptic patients in Basra province . Subjects and Methods: Forty seven epileptic patients, their ages range from 2.5 - 45 years (22 females and 25 males) and 109 apparently healthy volunteers as a control group with ages range between 2 - 80 years (59 females and 50 males ) were enrolled in this study. The study was done during the period from December 2017 to November 2018 at The Pediatric and Neurology Consulting Clinic of Basra Teaching Hospital. The risk and epidemiologic factors were assessed by a special questionnaire which was completed by the patients themselves or their relative. Immunoglobulin G (IgG) and cytokines were assessed by using ELISA while IgE by immunoturbidimetric assay by using the Abbott ARCHITECT c System for every epileptic patient as well as control group. Results: Sixteen (34.04%) of epileptic patients were seropositive for Toxocara antibody (IgG ) in comparison with 2 (1.83%) of control group with significant difference between them (p=0.0001). There was no significant association between seropositive and seronegative epileptic patients in regard to characteristic features of the studied population (sex and age) and risk factors (residence, exposure to soil, animal ownership, presence of home garden, onychophagia, thumb sucking, medicine intake, family history, duration of epilepsy and occupation) except geophagia . But interestingly, there were elevated in risk ratio for 5 variables including onychophagia (1.7), thumb sucking (2.1), geophagia (3.4), medication intake (1.1) and family history (1.7), when it is evaluated by Chi-squared “Fisher exact test” (risk ratio >1). The immunological assessments reveal an elevation IgE and IL-10 level in seropositive group in comparison seronegative group without a significant difference, while IL-6 concentration is elevated in theseronegative group. Conclusion: In epileptic patients in Basra province, infection with Toxocara spp may play role as a risk factor for idiopathic epilepsy. Risk factors such as onychophagia, geophagia, thumb sucking, medication intake and family history may increase risk infection with Toxocara spp in epileptic patients. Also toxocariasis may lead to elevation of IgE and IL-10 levels in these patients but it appears has a weak influence on concentration of IL-6.
Библиографические ссылки
Al-Azizz S A E. Epidemiological and sero- immunological studies of Toxocara canis with record of some species of intestinal helminthes from stray dogs in Basrah Governorate. Ph.D. Thesis, College of Education, University of Basrah, 2005.
Alderete J M. Jacob C M. Pastorino A C. Rubinsky- Elefant G. Castro A P. Fomin A B. et al. Prevalence of Toxocara infection in schoolchildrenfrom the Butantã region, São Paulo, Brazil. Mem Inst Oswaldo Cruz,2003;98:593-597.
Akyol A. Bicerol B. Ertug s. Ertabaklar H and Kiylioglu N. Epilepsy and seropositivity rates of Toxocaracanis and Toxoplasma gondii. Seizure , 2007;16: 233-237
Allahdin S. Khademvatan S. Rafiei A. Momen A. and Rafiei R. Frequency of Toxoplasma and Toxocara sp. antibodies in epileptic patients, in south western Iran. Iran. J. Child. Neurol,2015; 9: 32−40.
Andrade L D. Aspectos clinico-epidemiológicos da toxocaríase humana. Rev Patol Trop,2000; 29: 147– 159.
Arpino C. Gattinara G C. Piergili D. and Curatolo P. Toxocara infection and epilepsy in children: a case- control study. Epilepsia,1990;31:33-36.
Bachli H. Minet J C. Gratzl O. Cerebral toxocariasis: a possible cause of epileptic seizure in children. Childs Nerv Syst,2004; 20:468–472.
Caldera F. Burlone M E. Genchi C. Pirisi M. and Bartoli E. Toxocara encephalitis presenting with autonomous nervous system involvement. Infection ,2013;41: 691– 694.
Critchley E M. Vakil S D. Hutchinson D N. and Taylor P. Toxoplasma, Toxocara, and epilepsy. Epilepsia, 1982;23:315-321.
Del Prete G. DeCarli M. Almerigogna F. Giudizi M G. Biagiotti R. and Romagnani S. Human IL- 10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J fmmunol ,1993;150, 353-360.
Deshayes S. Bonhomme J. and de La Blanchardière A. Neurotoxocariasis: a systematic literature review. Infection 2016; 44: 565–574.
Długosz E. Wasy K. Klockiewicz M. and Wiśniewski M. Toxocara canis mucins among other excretory-secretary antigens induce in vitro secretion of cytokines by mouse splenocytes Parasitol Res ,2015; 114: 3365–3371.
El-Tantawy N L. El-Nahas H A. Salem D A. Salem N A. and Hasaneen B M. Seroprevalence of Toxoplasma gondii and Toxocara spp. in children with cryptogenic epilepsy. Am J Infect Dis Microbiol.,2013; 1:92–95.
Eraky M A. Abdel-HadyS. Abdallah K F. Seropositivity of Toxoplasma gondii and Toxocara spp. in Children with Cryptogenic Epilepsy, Benha, Egypt. Korean J. Parasitol,2016;54: 335–338.
Fan C K. Liao C W. Cheng YC. Factors affecting disease manifestation of toxocarosis in humans: genetics and environment. Vet Parasitol,2013; 193:342–352.
Finsterer J. and Auer H. Neurotoxocarosis .Rev Inst Med Trop Sao Paulo,2007; 49:279-287.
Fragoso R P. Monteiro M B. Lemos E M. and Pereira F E. Anti-Toxocara antibodies detected in children attending elementary school in Vitoria, State of Espírito Santo, Brazil: prevalence and associated factors. Rev. Soc. Bras. Med. Trop,2011; 44:461-466.
Gillespie S H. and Hawkey P M. Medical Parasitology.1st ed.,New York,USA.Oxford University Press Inc ,1995.
GodhwaniN. and Bahna S L. Antiepilepsy drugs and the immune system Ann Allergy Asthma Immunol,2016; 117 :634-640.
Hamilton C M. Brandes S. Holland C V. and Pinelli E. Cytokine expression in the brains of Toxocara canis-
infected mice. Parasite Immunol,2008;30:181– 185.
Habluetzel A. Traldi G. Ruggieri ,Attili A R. Scuppa P. Marchetti R. et al.(003) .An estimation of Toxocara canis prevalence in dogs, environmental egg contamination and risk of human infection in the Marche region of Italy. Veterinary Parasitology. 113, 3- 4,243–252
Hotez P J. and Wilkins P P. Toxocariasis:Americaꞌs most common neglected infection of poverty and a helminthiasis of global importance? Plos Negl.Trop.Dis.,2009;3:400
Kanobana K. Vereecken K. Junco Diaz R. Sariego I. Rojas L. Bonet Gorbea M. et al. Toxocara seropositivity, atopy and asthma: a study in Cuban schoolchildren. Trop Med Intern Hlth,2013; 18:403-406. 24. Macpherson C N. The epidemiology and public health importance of toxocariasis: a zoonosis of global importance. Int J Parasitol,2013; 43: 999- 1008.
Nicoletti A. Bartoloni A. Reggio A. Bartalesi F. Roselli M. Sofia V.et al. Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology ,2002; 58:1256- 1261.
Nicoletti A. Sofia V. Mantella A. Vitale G. Contrafatto D. SorbelloV. et al. Epilepsy and toxocariasis: a case- control study in Italy. Epilepsia ,2008; 49: 594-599.
Othman A A. Abdel-Aleem GA. Saied EM. Mayah WW. Elatrash A M. Biochemical and immunopathological changes in experimental neurotoxocariasis. Mol. Biochem. Parasitol,2010; 172: 1- 8.
Pinelli E. Brandes S. Dormans J. Fonville M. Hamilton C M. Der Giessen J V. Toxocara canis: effect of inoculum size on pulmonary pathology and cytokine expression in BALB/c mice. Exp. Parasitol,2007;115: 76- 82.
Qualizza R. Incorvaia C. Grande R. Makri M. and Allegra L. Seroprevalence of IgG anti-Toxocara species antibodies in a population of patients with suspected allergy. Intern J. of General Med, 2011; 4:783-787.
Quinnell R J. Genetics of susceptibility to human helminth infection. Int J Parasitol ,2003; 33:1219- 1231.
Sadjjad i S M. Khosravi M. Mehrabani D. and Oryan A. Seroprevalence of Toxocara infection in school children in Shiraz, southern Iran. J Trop Pediat,2000;46:327-330.
Salama A M. Daoud A A Elshehawy A K. Othman A A. and Eid M M. Toxocariasis and Toxoplasmosis in Children with Idiopathic Epilepsy in Mid-Region of the Nile Delta, Egypt: Prevalence and Risk Factors. Int.J.Curr.Microbiol.App.Sci,2019;8: 760-775.
Liimatainen S. Fallah M. Kharazmi E. Peltola M. and Peltola J. Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy. J Neurol ,2009; 256:796-802.
Wagner R G. Newton C R. Do helminths cause epilepsy? Parasite Immunol,2009; 31: 697-705.
Won K Y. Kruszon-Moran D. Schantz P M. and Jones J L. National seroprevalence and risk factors for zoonotic Toxocara spp. Infection. Am. J. Trop. Med. Hyg,2008;79: 552-557.
Woodruff AW. Bisseru B. and Bowe JC, Infection with animal helminths as a factor in causing poliomyelitis and epilepsy. Br Med J,1966; 1:1576- 1579.
Xinou E. Lefkopoulos A. Gelagoti M. Drevelegas A. Diakou A. Milonas I. and Dimitriadis A S. CT and MR imaging findings in cerebral toxocaral disease. Am J Neuroradiol ,2003;24:714-718.
Youn Y A. Kim S J. Sung I K. Chung S Y. Kim Y H. Lee I G. Serial examination of serum IL-8, IL- 10 and IL- 1Ra levels is significant in neonatal seizures induced by hypoxic-ischaemic encephalopathy. Scand J Immunol,2012;76:286-293.
Zibaei M. Firoozeh F. Bahrami P. Sadjjadi S M. Investigation of anti-Toxocara antibodies in epileptic patients and comparison of two methods: ELISA and
Western blotting. Epilepsy Res Treat ,2013;15681.